Discovery of pyrazolo-thieno[3,2-d]pyrimidinylamino-phenyl acetamides as type-II pan-tropomyosin receptor kinase (TRK) inhibitors: Design, synthesis, and biological evaluation-Reference-Cited by-同舟云学术

Discovery of pyrazolo-thieno[3,2-d]pyrimidinylamino-phenyl acetamides as type-II pan-tropomyosin receptor kinase (TRK) inhibitors: Design, synthesis, and biological evaluation

Published:2021-04 Issue: Volume:216 Page:113265
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

Yan Wei,Zhang Lingtian^ORCID,Lv Fengping,Moccia Marialuisa,Carlomagno Francesca,Landry Christophe^ORCID,Santoro Massimo^ORCID,Gosselet Fabien^ORCID,Frett Brendan^ORCID,Li Hong-yu^ORCID

Funder

University of Arkansas for Medical Sciences

National Cancer Institute

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Pharmacology,General Medicine

Reference42 articles.

1. TrkB phosphorylation by Cdk5 is required for activity-dependent structural plasticity and spatial memory;Lai;Nat. Neurosci.,2012

2. Trk receptors: roles in neuronal signal transduction;Huang;Annu. Rev. Biochem.,2003

3. Insights into current tropomyosin receptor kinase (TRK) inhibitors: development and clinical application;Yan;J. Med. Chem.,2019

4. NTRK gene fusions as novel targets of cancer therapy across multiple tumour types;Amatu;ESMO Open,2016

5. A human oncogene formed by the fusion of truncated tropomyosin and protein tyrosine kinase sequences;Martin-Zanca;Nature,1986

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discovery of 9H-pyrimido[4,5-b]indole derivatives as dual RET/TRKA inhibitors;Bioorganic & Medicinal Chemistry;2024-05

2. Design of new small molecules derived from indolin-2-one as potent TRKs inhibitors using a computer-aided drug design approach;Journal of Biomolecular Structure and Dynamics;2024-01-13

3. Schiff base compounds constructed from pyrazole–acetamide: Synthesis, spectroscopic characterization, crystal structure, DFT, molecular docking and antioxidant activity;Journal of Molecular Structure;2024-01

4. Discovery of Tropomyosin Receptor Kinase Inhibitors as New Generation Anticancer Agents: A Review;Current Topics in Medicinal Chemistry;2024-01

5. Classification models for predicting the bioactivity of pan-TRK inhibitors and SAR analysis;Molecular Diversity;2023-11-01